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 Summary 
 
International experts from multiple disciplines gathered at Homerton College in Cambridge, UK 
from September 12-14, 2018 to consider recent advances and emerging opportunities in the 
clonal tracking of hematopoiesis in one of a series of StemCellMathLab workshops. The group 
included thirty-five participants with experience in the fields of theoretical and experimental 
aspects of clonal tracking, and ranged from PhD students to senior professors. Data from a variety 
of model systems as well as from clinical gene therapy trials were discussed alongside strategies 
for data analysis and sharing, as well as challenges arising due to underlying assumptions in data 
interpretation and communication. Recognizing the power of this technology underpinned a group 
consensus of a need for improved mechanisms for sharing data and analytical protocols to 
maintain reproducibility and rigor in its application to complex tissues.  
 
Introduction 
 
Methods to unambiguously mark individual cells and follow their clonal progeny over extended 
periods of time can provide unprecedented insights into the organizational principles operative in 
tissue homeostasis and regeneration. The potential of clonal tracking was initially demonstrated 
by studies of glucose-6-phosphate dehydrogenase (G-6-PD) cellular mosaicism (Fialkow 1980, 
Abkowitz, Ott et al. 1985). More recently, viral integration site analysis (IS) (Jordan and Lemischka 
1990),(Schmidt, Glimm et al. 2001),(Biasco, Pellin et al. 2016) and integration of unique genetic 
“barcode” sequences (Gerrits, Dykstra et al. 2010),(Naik, Perie et al. 2013),(Lu, Neff et al. 
2011),(Cornils, Thielecke et al. 2014) have been complemented by inducible transposon systems 
(Sun, Ramos et al. 2014),(Rodriguez-Fraticelli, Wolock et al. 2018) and the recombination of 
multiple segments separated by loxP sites to generate uniquely identifiable barcodes in vivo (Pei, 
Feyerabend et al. 2017). Much of this work has focused on elucidating the process of 
hematopoiesis and in this context has recently played a major role in revealing significant 
heterogeneity in populations previously considered as homogeneous in their potential. Clonal 
tracking has also helped to elucidate the dynamics of naïve versus post-transplantation 
hematopoiesis, and is now stimulating new ideas about hematopoietic differentiation processes. 
Rapid technological developments and reduced costs of genomic sequencing are also now 
promoting the introduction of new approaches in cellular barcoding with anticipated increased 
impact on understanding mechanisms controlling hematopoiesis in vivo. 
  
As with any new technology, different experimental applications have led to a spectrum of 
solutions. These often involve different assumptions that impact the interpretation of derived 
datasets. As an example, variations in experimental protocols for DNA barcoding and related 
analytical tools have limited the comparison of results from related studies. The wealth of data 
present in clonal tracking studies also generates new challenges on quality control, data 
management and bioinformatic analysis. In addition, addressing system-wide questions regarding 
cell intermediates and population dynamics often requires the use of advanced mathematical and 
computational methods that can pose challenges for biologists who may be unfamiliar with the 
underlying assumptions and applicability of specific approaches. In particular, reconstruction of 
 differentiation pathways can impose several analytical and numerical challenges, especially when 
sampling depth is limited. 
  
The StemCellMathLab workshop, which took place at Homerton College, Cambridge, UK on 
September 12th to 14th, focused on the central issue of how best to produce and make use of 
quantitative clonal data. There was clear consensus on the need for the development and sharing 
of field-standard tools, as well as for the compulsory deposition of cellular barcoding datasets in 
an online repository.    
 
What’s in a name? That which we call a cell state by any other name...   
 
Description and reporting of experimental findings are usually language-based to convey the 
experimental approaches and results, as well as to define an underlying framework. Such 
descriptions commonly mean different things to different people. For example, the term 
“hematopoietic stem cells” has been variably used to refer to populations of cells that display 
certain functional activities (regeneration after irradiation), or a common set of cell surface 
markers, or more generally to the concept of a self-maintaining multipotent cell population. 
Similarly, a “clone” can relate to an entire organism (e.g., “Dolly” the sheep), the entire progeny 
arising from a uniquely marked founder cell or simply to a population of cells that share certain 
genetic aberrations (e.g., a mutant clone in cancer). However, the term “clone” becomes 
unambiguous if the unique mark identifying the founder cell is specified, be it a DNA barcode, a 
particular mutation, or a single cell from which a clone in vitro has been derived. Going forward, 
precise definitions will be critical to avoid confusion and facilitate replication of findings. 
  
This issue is particularly important to analyses of the stages of hematopoietic cell differentiation, 
and hence to the majority of clonal tracking studies. Historically, the structure of this process has 
been greatly informed by flow cytometric isolation of cell populations with decreasing lineage and 
proliferative activity (Bryder, Rossi et al. 2006),(Eaves 2015),(Wahlestedt and Bryder 2017). The 
prospective isolation of these cell populations has also enhanced reproducibility in various clinical 
applications. However, a number of exceptions have emerged that argue against the concept of 
describing this process in terms of discrete and intrinsically homogeneous cell populations. 
Heterogeneity in cell function (Sieburg, Cho et al. 2006),(Dykstra, Kent et al. 2007) and molecular 
profiling (Paul, Arkin et al. 2015),(Wilson, Kent et al. 2015), as well as evidence of many 
intermediate molecular states (Nestorowa, Hamey et al. 2016),(Cabezas-Wallscheid, Buettner et 
al. 2017), now suggest that much of hematopoietic cell differentiation has features of a continuous 
process in which the molecular state (and phenotypic profile) of a cell changes more dynamically 
than originally envisaged. This makes snapshot measurements of enriched but non-
homogeneous populations difficult to interpret, and the field clearly lacks mathematical tools to 
deal with a continuum or variable paradigms. This is a key area in which modelling and inference 
should advance future understanding of hematopoiesis. 
 
Discussion of these issues led to a convergence on two areas. The first focused on strategies 
that would improve clarity about cell population descriptions; for example, by provision of flow 
cytometric gating details, and results of measurements of the proportion of cells in a given 
 population that displayed assigned functional properties. The second focused on the tools needed 
to collect and model dynamically changing properties of cells.   
 
 
I’ll believe it when I see it (and can do it)... 
 
A recurring theme was the need to improve reproducibility, robustness and utility of datasets in 
the clonal tracking field. Difficulties in accessing and re-analyzing published datasets were noted 
and a frequent lack of published information about viral barcode libraries and the composition of 
barcoded samples was also felt to be a significant deficiency, recognizing a potential exception 
for barcoding data obtained on clinical subjects. There was thus much support for the concept of 
a central online repository being established that could accept standard format barcoding data as 
this would enable such information for most experimental studies to become a standard 
publication requirement, as is already the case for other types of large datasets. 
 
Specific recommendations proposed to address these issues were as follows: 
 
1. Provide all data necessary for the re-analysis of the major claims in the publication, in both 
raw and processed format.  
2. Provide an informative description of the data and how they were produced. 
3. Provide a clear description of the bioinformatics pipeline used, as well as of any modelling 
or statistical inference procedures.  
4. Ensure the accessibility of all necessary software, including the specific code to reproduce 
tables, figures and other analyses. 
 
The range of experimental and analytical methods used in clonal tracking makes it impossible to 
produce comprehensive standards for reporting barcode data. Nevertheless, minimum 
requirements for the implementation and reporting of barcoding experiments could be introduced; 
e.g., barcode detection levels, data filters used, numbers of barcoded and transplanted cells, and 
details of whether absolute or fractional numbers were used for reporting. Furthermore, for IS and 
in vivo genomic recombination barcoding, where the overlap between observed barcodes in 
different samples is often very low, attempts to circumvent this problem could be clearly 
described. 
 
There was also agreement that analysis pipelines would benefit from clearer descriptions and 
improved accessibility of codes used. A major barrier to the reproducibility of barcoding data 
analysis is that, unlike other high-dimensional data types such as single-cell RNA-seq, the clonal 
tracking field does not have many applicable open source R packages. Some workshop 
participants expressed interest in creating such R packages, and/or making existing ones 
available. Such a step forward would not constitute a definitive analysis pipeline, but would make 
many of the unavoidable decisions involved in the preliminary processing of barcoding data more 
transparent, e.g., choices on read thresholds and barcode sequence error correction. This 
approach could also provide methods for data visualization and enable new methods to be more 
rapidly disseminated. Box 1 summarizes key recommendations for data and code provision. 
  
An example of this kind of toolbox, comprising several user-friendly and customizable R 
packages, has been recently developed (Thielecke et al, under revision) and can be downloaded 
at https://cran.r-project.org/web/packages/genBaRcode/index.html. The workflow starts with 
barcode extraction from the raw sequencing files, independently of the known barcode library. 
After matching to the library allowing insertions and deletions in the reads, an error-correction 
procedure merges highly similar barcodes, assuming that small sequence differences are most 
likely the result of PCR errors (Thielecke, Aranyossy et al. 2017). The resulting barcode counts 
can be visualized in multiple ways, including histograms, graphical networks and tree-like 
structures. The complete R code is available allowing customization of the package. 
 
As barcoding data starts to be combined with other functional measurements; e.g., scRNA-seq 
(Spanjaard, Hu et al. 2018),(Wagner, Weinreb et al. 2018),(Alemany, Florescu et al. 2018),(Raj, 
Wagner et al. 2018), or cell cycle measurements (Griessinger, Vargaftig et al. 2018), visualization 
of data becomes increasingly challenging. The chosen method will depend on data type and 
question(s) being posed, but figures that are informative and easily interpretable will reduce 
current challenges. A common toolbox (e.g., a set of dedicated R packages) for people to work 
from would thus be a major boon for the field (see attached example).  
 
Box 1: Practical guidelines for making data and code available 
 
Code availability 
A. Open access code repository e.g. GitHub 
B. Provision of code to generate each figure appearing in a paper (together with the source 
data where feasible) 
C. Pre-processed data files deposited together with the code 
 
Data availability 
A. Deposit data in an online repository 
B. Raw data should be made available as FASTQ file or counts matrix  
C. Reference file of the sequencing of the plasmid library should be made available (where 
possible, construction details of the library provided in a publication)     
D. Metadata should be unambiguous and allow for identification of each sample (“column” in 
the counts matrix) without additional information, as well as, sequence file id, animal, 
tissue, time, sort details and other relevant information 
 
Human blood cell production barcoding experiments: making the most of gene therapy 
trials 
 
The reliance of human hematopoietic cell biology on retrospective functional transplantation 
assays has traditionally posed major limitations on understanding the workings of this system. 
Animal models, where experimental bone marrow transplantation is now well established, have 
therefore become the mainstay of the field. For assessing the functional activity of human cells, 
researchers have generally relied on in vitro assays and xenotransplantation into immunodeficient 
 animals, or have drawn inferences from primate transplant models, each of which has drawbacks. 
Fortuitously, gene therapy trials are increasing in number and are now providing unique access 
to the clonal dynamics of human hematopoiesis in various clinical contexts. Although the main 
concerns in gene therapy trials are patient safety and treatment efficacy, associated analyses 
provide an unprecedented source of data about short and long-term clonal contributions and their 
stable and changing diversity of progeny outputs in humans (Aiuti, Biasco et al. 2013),(Biasco, 
Pellin et al. 2016).   
 
Historically, these data relied primarily on the identification of viral integration sites (VIS). Recently 
developed methods (Zhou, Bonner et al. 2014) have shown all VIS in a sample can now be 
recovered, although previous percentages recovered were much lower (60-80%) (Schmidt, 
Schwarzwaelder et al. 2007),(Kustikova, Baum et al. 2008),(Gabriel, Eckenberg et al. 2009). 
Nevertheless, quantification of clone numbers based on sequencing reads is inherently imprecise 
(Cornils, Bartholomae et al. 2013),(Brugman, Suerth et al. 2013). Methods used to quantify clonal 
data in humans likewise need to be described clearly to allow comparison across trials.  
 
An enormous amount of ambiguity surrounds many gene therapy datasets. This is due both to 
differences in the underlying diseases and technical differences in the methods used to quantify 
clonal abundance. Each trial is necessarily governed by different authorities with center- and 
disease-specific regulations that include limitations on the number of samples available for 
analysis. Provision of primary sequencing data might thus be limited by the use of proprietary 
vectors in addition to a patient’s right to protect their genomic information. However, independent 
explicit descriptions of sample preparation, transduction and transplantation parameters, and 
details of data processing and quantification, sequencing platform used, IS calling, thresholds and 
noise filtering details are essential to enable independent interpretation of reported data. Creation 
and adoption of common standards to assess data and conclusions, developed by a group of 
specialists in this area, would thus be very helpful to the field. 
 
Seeing the forest using the trees 
 
With the advent of new experimental methods to track clones in vivo (e.g. (Sun, Ramos et al. 
2014), (McKenna, Findlay et al. 2016), (Alemany, Florescu et al. 2018),(Raj, Wagner et al. 2018), 
(Spanjaard, Hu et al. 2018), (Wagner, Weinreb et al. 2018),(Maetzig, Morgan et al. 2018) and the 
rapid expansion in the size of datasets, many statistical and mathematical modelling approaches 
have been developed to conduct inferences from the data. These approaches are becoming 
extremely important to deriving information about the dynamics of hematopoiesis in vivo.  
 
Improved reporting of model assumptions could permit more rigorous evaluation of current data 
and the validity of model-based conclusions from both a biological and mathematical perspective. 
As in the case of deciding which experimental assay to implement, the choice of a mathematical 
model is generally determined by a trade-off between its applicability to the biological situation 
and practical considerations, from the ease of equation manipulation (i.e., the availability of 
closed-form solutions or approximations) to the feasibility of parameter inference methods. From 
a theoretical point of view, these “practical considerations” usually result in assumptions that do 
 not fully match the experimental setting. It is thus crucial that these assumptions are made as 
explicit as they would be in a mathematical journal, so that the validity of the trade-off can be 
assessed. For example, most formalisms used to model barcoding data (e.g., branching 
processes, Markov chains, etc) assume the independence of division and cell fate decisions 
because, in practice, this is necessary in order to analyze the models. This is akin to the use of 
antibodies to measure cell identity, another practical assumption that has fallacies.   
 
On the inference side, custom-made and complicated pipelines for parameter inference or model 
selection can also be a source of problems as they are not typically subject to the same level of 
scrutiny as other aspects of data analysis. Clearer descriptions of inference methodologies used 
would help to address this challenge. 
 
In terms of specific enhancements to clonal tracking experiments, there was consensus that the 
addition of functional information to barcode counts would help to specify essential parameters of 
the model. For example, when inferring self-renewal, differentiation and death rates, 
measurements of cell cycle, apoptosis, and cellular state transition time can be hugely 
informative. This additional data is also important to embed fate decisions in the context of 
regulatory pathways. It was felt that this type of data will rapidly emerge, particularly as barcoding 
is combined with single-cell RNA-sequencing, and the time is ripe for developing the 
modelling/analysis strategies to make use of such data.  
 
Looking toward the future of building mechanistic models describing hematopoiesis, approaches 
for reconstructing trees have been borrowed or adapted from the field of phylogenetics, 
particularly to analyze data from in vivo genomic recombination tracking methods and 
retrospective methods based on division-linked mutations (Shlush, Chapal-Ilani et al. 
2012),(McKenna, Findlay et al. 2016),(Frieda, Linton et al. 2017),(Lee-Six, Obro et al. 2018), 
(Alemany, Florescu et al. 2018),(Raj, Wagner et al. 2018),(Spanjaard, Hu et al. 
2018),(Griessinger, Vargaftig et al. 2018). While these approaches have not yet been robustly 
validated by, for example, combining them with virally-introduced barcoding approaches, 
experiments of this type would allow benchmarking of the various tree reconstruction methods. 
 
Future Perspective 
 
This workshop highlighted the potential that clonal tracking has to gain from close interactions 
between experimentalists and theoreticians. As datasets grow in size and complexity, it will be 
critical to develop increasingly robust assessment tools to establish ways that facilitate data 
interpretation and permit a broader understanding of hematopoiesis beyond single experiments.  
A more complete understanding of the journeys that primitive cells and their progeny may make 
to produce all types of mature cells throughout life will greatly inform efforts to generate these ex 
vivo. Being able to predict the clonal dynamics of a mutant clone relative to normal cells or being 
able to robustly assess the success, failure, or potential dangers of a graft in cellular and gene 
therapies may also be possible to realize in the future. Dynamic models of such processes will 
become more robust as more accurate and comprehensive information is contributed by 
 experimentalists, and the iterative process of building such models will also be facilitated by better 
(and more) sharing of data and associated analytical methods.   
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